+
Site Tour

Search

Showing 31 - 40 of 445 results.

  • Voice of the experts

    STABLE DELIVERY. REMARKABLE PERFORMANCE. FUTURE READY.   STABLE DELIVERY REMARKABLE PERFORMANCE FUTURE READY WATCH TAVI SUMMIT: TAVI SUMMIT 2024 TAVI SUMMIT 2023

  • Clinical Data

    2-Year OUTCOMES from the triluminate pivotal trial New TriClip™ Transcatheter Edge-to-Edge Repair clinical data release   EXPLORE NOW INSPIRED BY PATIENTS. MADE POSSIBLE BY YOU. TriClip TE

  • Clinical Data

    MitraClip™ + GDMT patients were more likely to be in NYHA functional class I or II throughout the 5 years MitraClip™ + GDMT patients benefited from a 47% relative risk reduction in HFH/ Death versu

  • Therapy

    SWITCH TO THE interventional VIEW    For more information specific to interventional cardiology regarding LAA Occlusion HOW DOES IT WORK? SUPPORTED BY GUIDELINES, PROVEN BY DATA PROVEN R

  • Clinical Data

    SWITCH TO THE REFERRAL VIEW    For more information specific to neurology regarding LAA Occlusion STROKE RISK REDUCTION AND FREEDOM FROM ANTICOAGULANTS Clinical studies have shown

  • Clinical Data

    The objective of this trial is to evaluate the safety and effectiveness of the Amulet™ LAA Occluder compared to NOAC therapy in patients with non-valvular AF at increased risk for ischemic stroke an

  • Options

    As recommended in the 2020 American College of Cardiology/American Heart Association (ACC/AHA) and 2021 ESC/EACTS guidelines,38,39 patients with TR should be managed by a multidisciplinary heart tea

  • AV Valves SUMMIT 2024

    ON DEMAND AV VALVES SUMMIT 2024 2nd International edition of the AtrioVentricular Valves Summit DAY 1: TRICUSPID FOCUS DAY 2: MITRAL AND AV VALVES FOCUS

  • Overview

    Defect size as noted below is presented as a percentage of the aortic annulus diameter. A small VSD of ≤ 25% has small left-to-right shunts and no LV volume overload. These VSDs usually have a very

  • Recommendations

    EXPLORE VSD SOLUTIONS Amplatzer Muscular occluder for ventricular septal defect

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline